Article Text

Download PDFPDF
Randomised controlled trial
Symptoms of obstructive sleep apnoea are treated by adenotonsillectomy, but without change in neurocognitive outcome
  1. James D Ramsden
  1. Department of ENT, John Radcliffe Hospital, Oxford University Hospitals, Oxford, Oxfordshire, UK
  1. Correspondence to : James D Ramsden, Department of ENT, John Radcliffe Hospital, Oxford University Hospitals, West Wing, Oxford, Oxfordshire OX3 9DU, UK; james.ramsden{at}ouh.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Context

Adenotonsillectomy (T&A) in children is a very common surgical intervention for sleep disordered breathing and obstructive sleep apnoea (OSA). OSA in children causes cardiovascular, behavioural, developmental and cognitive sequelae. Controversies exist about many aspects of this condition including diagnosis, treatment and perioperative management.

In children with severe OSA there are neurocognitive deficits and altered brain development.1 There is a body of evidence to support the effectiveness of T&A in improving polysomnograms (PSG) and quality of life in OSA, but there are fewer studies that show T&A treats neurocognitive deficits, although there is a widely held belief that this is the case. The majority of children undergoing T&A for OSA have mild or moderate OSA, and several small series and case studies have identified small, but measurable, deficits in …

View Full Text

Footnotes

  • Competing interests None.